|Evidence for camel-to-human transmission of MERS coronavirus|
EI Azhar, SA El-Kafrawy, SA Farraj, AM Hassan, MS Al-Saeed, ...
New England Journal of Medicine 370 (26), 2499-2505, 2014
|Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience|
AA Algaissi, NK Alharbi, M Hassanain, AM Hashem
Journal of infection and public health 13 (6), 834-838, 2020
|The role of lipid metabolism in COVID-19 virus infection and as a drug target|
M Abu-Farha, TA Thanaraj, MG Qaddoumi, A Hashem, J Abubaker, ...
International Journal of Molecular Sciences 21 (10), 3544, 2020
|CORRESPONDENCE: Evidence for camel-to-human transmission of MERS coronavirus.|
TA Madani, EI Azhar, AM Hashem
The New England journal of medicine 371 (14), 1359-1360, 2014
|Detection of the Middle East respiratory syndrome coronavirus genome in an air sample originating from a camel barn owned by an infected patient|
EI Azhar, AM Hashem, SA El-Kafrawy, SS Sohrab, AS Aburizaiza, ...
MBio 5 (4), e01450-14, 2014
|Universal anti-neuraminidase antibody inhibiting all influenza A subtypes|
TM Doyle, AM Hashem, C Li, G Van Domselaar, L Larocque, J Wang, ...
Antiviral research 100 (2), 567-574, 2013
|Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review|
AM Hashem, BS Alghamdi, AA Algaissi, FS Alshehri, A Bukhari, ...
Travel medicine and infectious disease 35, 101735, 2020
|Immunogenicity of candidate MERS-CoV DNA vaccines based on the spike protein|
SS Al-Amri, AT Abbas, LA Siddiq, A Alghamdi, MA Sanki, MK Al-Muhanna, ...
Scientific reports 7 (1), 1-8, 2017
|iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2|
Z Ali, R Aman, A Mahas, GS Rao, M Tehseen, T Marsic, R Salunke, ...
Virus research 288, 198129, 2020
|Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences|
C Gravel, C Li, J Wang, AM Hashem, B Jaentschke, K Xu, B Lorbetskie, ...
Vaccine 28 (36), 5774-5784, 2010
|Universal antibodies against the highly conserved influenza fusion peptide cross-neutralize several subtypes of influenza A virus|
AM Hashem, G Van Domselaar, C Li, J Wang, YM She, TD Cyr, J Sui, ...
Biochemical and biophysical research communications 403 (2), 247-251, 2010
|Humoral immunogenicity and efficacy of a single dose of ChAdOx1 MERS vaccine candidate in dromedary camels|
NK Alharbi, I Qasim, A Almasoud, HA Aljami, MW Alenazi, A Alhafufi, ...
Scientific reports 9 (1), 1-11, 2019
|Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases|
AM Hashem, AS Flaman, A Farnsworth, EG Brown, G Van Domselaar, ...
PloS one 4 (12), e8350, 2009
|A highly immunogenic, protective, and safe adenovirus-based vaccine expressing Middle East respiratory syndrome coronavirus S1-CD40L fusion protein in a transgenic human …|
AM Hashem, A Algaissi, AS Agrawal, SS Al-Amri, RY Alhabbab, ...
The Journal of infectious diseases 220 (10), 1558-1567, 2019
|Complete genome sequencing and phylogenetic analysis of dengue type 1 virus isolated from Jeddah, Saudi Arabia|
EI Azhar, AM Hashem, SA El-Kafrawy, S Abol-Ela, AMM Abd-Alla, ...
Virology journal 12 (1), 1-11, 2015
|SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients|
A Algaissi, MA Alfaleh, S Hala, TS Abujamel, SS Alamri, SA Almahboub, ...
Scientific reports 10 (1), 1-10, 2020
|A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains|
TM Doyle, C Li, DJ Bucher, AM Hashem, G Van Domselaar, J Wang, ...
Biochemical and biophysical research communications 441 (1), 226-229, 2013
|Inactivation of Middle East respiratory syndrome‐coronavirus in human plasma using amotosalen and ultraviolet A light|
SI Hindawi, AM Hashem, GA Damanhouri, SA El‐Kafrawy, AM Tolah, ...
Transfusion 58 (1), 52-59, 2018
|Prospects of HA-based universal influenza vaccine|
BioMed research international 2015, 2015
|Targeting the HA2 subunit of influenza A virus hemagglutinin via CD40L provides universal protection against diverse subtypes|
X Fan, AM Hashem, Z Chen, C Li, T Doyle, Y Zhang, Y Yi, A Farnsworth, ...
Mucosal immunology 8 (1), 211-220, 2015